Anti-inflammatory Effect of Simvastatin in an Experimental Model of Spinal Cord Trauma: Involvement of PPAR-α

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2012 Apr 28

PMID 22537532

Citations 37

Authors

Emanuela Esposito

Barbara Rinaldi

Emanuela Mazzon

Maria Donniacuo

Daniela Impellizzeri

Irene Paterniti

Annalisa Capuano

Placido Bramanti

Salvatore Cuzzocrea

Affiliations

Soon will be listed here.

Abstract

Background: Statins such as simvastatin are inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase used in the prevention of cardiovascular disease. In addition to their cholesterol-lowering activities, statins exert pleiotropic anti-inflammatory effects, which might contribute to their beneficial effects on lipid-unrelated inflammatory diseases. Recently it has been demonstrated that the peroxisome proliferator-activated receptor (PPAR)-α mediates anti-inflammatory effects of simvastatin in vivo models of acute inflammation. Moreover, previous results suggest that PPAR-α plays a role in control of secondary inflammatory process associated with spinal cord injury (SCI).

Methods: With the aim to characterize the role of PPAR-α in simvastatin activity, we tested the efficacy of simvastatin (10 mg/kg dissolved in saline i.p. 1 h and 6 h after the trauma) in an experimental model of SCI induced in mice by extradural compression of the spinal cord (T6-T7 level) using an aneurysm clip with a closing force of 24 g via a four-level T5-T8 laminectomy, and comparing mice lacking PPAR-α (PPAR-α KO) with wild type (WT) mice. In order to elucidate whether the effects of simvastatin are due to activation of the PPAR-α, we also investigated the effect of a PPAR-α antagonist, GW6471 (1 mg/kg administered i.p. 30 min prior treatment with simvastatin) on the protective effects of on simvastatin.

Results: Results indicate that simvastatin activity is weakened in PPAR-α KO mice, as compared to WT controls. In particular, simvastatin was less effective in PPAR-α KO, compared to WT mice, as evaluated by inhibition of the degree of spinal cord inflammation, neutrophil infiltration, nitrotyrosine formation, pro-inflammmatory cytokine expression, nuclear factor (NF)-κB activation, inducible nitric-oxide synthase (iNOS) expression, and apoptosis. In addition we demonstrated that GW6471 significantly antagonized the effect of the statin and thus abolished the protective effect.

Conclusions: This study indicates that PPAR-α can contribute to the anti-inflammatory activity of simvastatin in SCI.

Citing Articles

How PPAR-alpha mediated inflammation may affect the pathophysiology of chronic kidney disease.

Masenga S, Desta S, Hatcher M, Kirabo A, Lee D Curr Res Physiol. 2024; 8:100133.

PMID: 39665027 PMC: 11629568. DOI: 10.1016/j.crphys.2024.100133.

Gemfibrozil Improves Microcirculatory Oxygenation of Colon and Liver without Affecting Mitochondrial Function in a Model of Abdominal Sepsis in Rats.

Kuebart A, Gross K, Maicher C, Sonnenschein M, Raupach A, Schulz J Int J Mol Sci. 2024; 25(1).

PMID: 38203431 PMC: 10778839. DOI: 10.3390/ijms25010262.

Pravastatin Improves Colonic and Hepatic Microcirculatory Oxygenation during Sepsis without Affecting Mitochondrial Function and ROS Production in Rats.

Kuebart A, Gross K, Ripkens J, Tenge T, Raupach A, Schulz J Int J Mol Sci. 2023; 24(6).

PMID: 36982530 PMC: 10052315. DOI: 10.3390/ijms24065455.

Tailoring of Novel Bile Salt Stabilized Vesicles for Enhanced Transdermal Delivery of Simvastatin: A New Therapeutic Approach against Inflammation.

Khafagy E, Almutairy B, Lila A Polymers (Basel). 2023; 15(3).

PMID: 36771977 PMC: 9921379. DOI: 10.3390/polym15030677.

Fatty Acid Amide Hydrolase Deficiency Is Associated with Deleterious Cardiac Effects after Myocardial Ischemia and Reperfusion in Mice.

Rajlic S, Surmann L, Zimmermann P, Weisheit C, Bindila L, Treede H Int J Mol Sci. 2022; 23(20).

PMID: 36293543 PMC: 9604059. DOI: 10.3390/ijms232012690.

References

Sharma S, Dhar A, Kaundal R . FeTPPS protects against global cerebral ischemic-reperfusion injury in gerbils. Pharmacol Res. 2007; 55(4):335-42. DOI: 10.1016/j.phrs.2007.01.002. View

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

Jasinska M, Owczarek J, Orszulak-Michalak D . Statins: a new insight into their mechanisms of action and consequent pleiotropic effects. Pharmacol Rep. 2007; 59(5):483-99. View

Szabo C . Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett. 2003; 140-141:105-12. DOI: 10.1016/s0378-4274(02)00507-6. View

Xiong Y, Rabchevsky A, Hall E . Role of peroxynitrite in secondary oxidative damage after spinal cord injury. J Neurochem. 2006; 100(3):639-49. DOI: 10.1111/j.1471-4159.2006.04312.x. View

Kota B, Huang T, Roufogalis B . An overview on biological mechanisms of PPARs. Pharmacol Res. 2005; 51(2):85-94. DOI: 10.1016/j.phrs.2004.07.012. View

Lovett-Racke A, Hussain R, Northrop S, Choy J, Rocchini A, Matthes L . Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease. J Immunol. 2004; 172(9):5790-8. DOI: 10.4049/jimmunol.172.9.5790. View

Benani A, Kremarik-Bouillaud P, Bianchi A, Netter P, Minn A, Dauca M . Evidence for the presence of both peroxisome proliferator-activated receptors alpha and beta in the rat spinal cord. J Chem Neuroanat. 2003; 25(1):29-38. DOI: 10.1016/s0891-0618(02)00093-5. View

Dhar A, Kaundal R, Sharma S . Neuroprotective effects of FeTMPyP: a peroxynitrite decomposition catalyst in global cerebral ischemia model in gerbils. Pharmacol Res. 2006; 54(4):311-6. DOI: 10.1016/j.phrs.2006.06.009. View

10.

Okamoto H, Iwamoto T, Kotake S, Momohara S, Yamanaka H, Kamatani N . Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis. Clin Exp Rheumatol. 2005; 23(3):323-30. View

11.

Genovese T, Mazzon E, Di Paola R, Cannavo G, Muia C, Bramanti P . Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma. Exp Neurol. 2005; 194(1):267-78. DOI: 10.1016/j.expneurol.2005.03.003. View

12.

DosReis G, Borges V, Zin W . The central role of Fas-ligand cell signaling in inflammatory lung diseases. J Cell Mol Med. 2004; 8(3):285-93. PMC: 6740074. DOI: 10.1111/j.1582-4934.2004.tb00318.x. View

13.

Paumelle R, Blanquart C, Briand O, Barbier O, Duhem C, Woerly G . Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway. Circ Res. 2006; 98(3):361-9. DOI: 10.1161/01.RES.0000202706.70992.95. View

14.

Liu P, Liu Y, Lin L, Chen J, Liao J . Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation. 2008; 119(1):131-8. PMC: 2745913. DOI: 10.1161/CIRCULATIONAHA.108.813311. View

15.

Fraunberger P, Grone E, Grone H, Walli A . Simvastatin reduces endotoxin-induced nuclear factor kappaB activation and mortality in guinea pigs despite lowering circulating low-density lipoprotein cholesterol. Shock. 2008; 32(2):159-63. DOI: 10.1097/SHK.0b013e318193c514. View

16.

Chittenden T, Harrington E, OConnor R, Flemington C, Lutz R, Evan G . Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 1995; 374(6524):733-6. DOI: 10.1038/374733a0. View

17.

Desvergne B, Wahli W . Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev. 1999; 20(5):649-88. DOI: 10.1210/edrv.20.5.0380. View

18.

Delerive P, Gervois P, Fruchart J, Staels B . Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators. J Biol Chem. 2000; 275(47):36703-7. DOI: 10.1074/jbc.M004045200. View

19.

Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muia C, Centorrino T . Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice. Lab Invest. 2004; 84(12):1643-54. DOI: 10.1038/labinvest.3700185. View

20.

Xu J, Kim G, Chen S, Yan P, Ahmed S, Ku G . iNOS and nitrotyrosine expression after spinal cord injury. J Neurotrauma. 2001; 18(5):523-32. DOI: 10.1089/089771501300227323. View